We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




通过检验发现癌症的BRCA2基因突变

By LabMedica International staff writers
Posted on 19 Mar 2018
临床基因检验发现了乳腺癌易感基因2 (BRCA2)的许多意义不明变异(VUS)。VUS形成一项严重的临床挑战,因为这些变体对癌症风险的促进作用尚不明确。

刚开发成功的一款检验产品能显示BRCA2基因里的哪些突变使妇女易生乳腺癌或卵巢癌。这款基于实验室的检验产品能确定BRCA2基因里的哪些遗传性VUS突变与癌症形成有关。

美国明尼苏达州罗彻斯特市梅奥诊所的科学家及其同事使用经过确证的BRCA2同源重组(HR) DNA修复活性的功能性测定全面评估了BRCA2 C末端DNA结合域(DBD)里的VUS,并定义了变异致病性的分类器。

在评估的139种变异中,54种的致病概率大于等于99%,73种的中性概率大于等于95%。比较功能性测定的结果与Align-GVGD蛋白序列预测算法预测变异致病性的结果,该算法以前一直用于变异的分类。相较HR测定,Align-GVGD预测的致病变异严重过头。

科研小组随后在一个贝叶斯分级模型(VarCall)中结合功能性测定与Align-GVGD的预测结果,估计每种VUS的总体致病概率。此外,为了预测所有其它BRCA2 DBD变异的作用,并优选供功能性研究的变异,他们用内表现型优化的序列集合(endoPhenotype-Optimized Sequence Ensemble, ePOSE)算法和HR功能性测定的数据训练BRCA2变异的分类器。

这项研究的高级研究员Fergus J. More...
Couch博士说:“迄今为止,我们只能确定BRCA2基因中的13个遗传性突变致癌。本次研究发现了54种突变会增加癌症风险。已知不会增加癌症风险的21个中性突变现在增加到73个。这些发现也许能帮助患者和医院更好地决定如何处理基因检验获得的信息。”该研究的论文发表于2018年1月25日的《美国人类遗传学杂志》(American Journal of Human Genetics)。

Related Links:
梅奥诊所


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
An overview of the study and findings: A) Several brain-derived EVPs cross the blood brain barrier and reach circulation. B) Different EVPs enrich different RNA cargo B) The EVP-RNA is impacted, upregulated (green) or downregulated (red) in AD (Gonzalez-Kozlova, E., et al., Nature Communications (2026). doi.org/10.1038/s41467-026-74541-8)

RNA Blood Test May Enable Earlier Alzheimer’s Disease Diagnosis

Alzheimer’s disease affects an estimated 55 million people worldwide and remains difficult to diagnose at an early stage. Diagnostic workups can be complicated by symptom overlap with other conditions,... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.